Home > Press > Amorphous Coordination Polymer Particles as alternative to classical nanoplatforms for nanomedicine
![]() |
Abstract:
Members of ICN2 Nanostructures Functional Materials Group published a series of works developing robust nanoparticles based on coordination polymers for application on theranostics (therapy + diagnosis). They opened a wide variety of possibilities into high added-value medical applications.
ICN2 Nanostructures Functional Materials (Nanosfun) Group develops robust nanoparticles based on coordination polymers for application on nanomedicine. A method to systematically control the surface functionality of Coordination Polymer Particles (CPPs) or to master their modification at the nanoscale has been reported and opened a wide variety of possibilities into high added-value medical applications. (1) This is especially relevant for drug delivery applications, diagnosis and/or recognition chemicals that allow for an enhanced biological activity, imaging, or stability.
Thus, the members of Nanosfun have envisioned the use of ligands bearing a reactive group that enables reproducible low-cost fabrication of nanoscale platforms and their post-synthetic modification. Moreover, the successful cytotoxicity of the new CPP nanoparticles loaded with antitumoral agents represents notable evidence of the potential utility of these CPPs as chemotherapeutic nanomedicines with high uptake and in vitro activity under low dosing regimen.
The different studies detail mechanistic investigation of the different guest release mechanisms that can take place on CPPs (diffusion, CPP degradation via surface erosion and undesired desorption from the particle surface). (2) The use of the coordination polymers sensitive to the environment or external stimuli developed within the group has allowed to design nanoplatforms with different release profiles in a switchable manner and controlled by the application of an external stimuli or as consequence of changes in the environment. (3)
These materials placed between pure organic polymeric nanoparticles and the metal nanoparticles intended to take advantage of the metal ion properties and their capacity of encapsulation to build multifunctional nanoplatforms with application on theranostics (therapy + diagnosis).
The ICN2 Nanosfun has developed this strategy, published recently in three articles with authors from ICN2, including the CSIC Professor and Group Leader Dr. Daniel Ruiz, Dr. Fernando Novio, Dr. Fabiana Nador or the PhD student Karolina Wnuk, and co-authors from the UAB. ICN2 researchers' work with these materials has resulted recently in the publication of three scientific papers in Chemistry - A European Journal (1-2) and Chemistry Communications (3) and a National Patent. (·)
Patent:
Sistema polimérico metaloorgánico de coordinación a escala micro-/nanométrica, procedimiento de obtención y aplicaciones. Pat. Appl. P201331869
####
For more information, please click here
Contacts:
Campus de la UAB
Edifici ICN2
08193 Bellaterra, Spain
Tel: +34 93 737 26 49
Fax: +34 93 737 26 48
Copyright © ICN2
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related Links |
Related News Press |
News and information
Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025
Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025
Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Discoveries
Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025
ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
Simple algorithm paired with standard imaging tool could predict failure in lithium metal batteries August 8th, 2025
Announcements
Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025
Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025
Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025
ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
Simple algorithm paired with standard imaging tool could predict failure in lithium metal batteries August 8th, 2025
First real-time observation of two-dimensional melting process: Researchers at Mainz University unveil new insights into magnetic vortex structures August 8th, 2025
Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |